AstraZeneca’s (AZ) AKT inhibitor Truqap (capivasertib) has been recommended by the National Institute for Health and Care ...

Bristol Myers Squibb (BMS) has announced that its dual immunotherapy combination has been approved by the US Food and Drug ...

Roche’s Columvi (glofitamab) has been approved by the European Commission (EC) as part of a combination treatment for diffuse ...

Equipping patients, carers and loved ones with the tools and understanding to make the choices that are right for them ...

London became the first UK health agency to gain B-Corp accreditation. CEO and Co-Founder, Matt Hunt reports back on life in ...

DDI LLC DDi is a prominent Technology partner to the Life Sciences industry. DDi has built its solution competency with a unique blend of functional and domain expertise to serve the technology needs ...

Prime Global- The medical communications people. Prime Global is a group of six full-service medical communications agencies and specialist consultancies. We provide the world’s leading biotech, ...

While AI is reshaping frontline healthcare at pace—spotting cancers, triaging patients, and summarising records—its uptake in ...

Novartis has unveiled plans to invest $23bn into its US-based infrastructure over the next five years, allowing it to produce ...

Johnson & Johnson (J&J) has announced that an injectable version of Rybrevant (amivantamab) has been approved by the European ...

Bayer’s Vitrakvi (larotrectinib) has been granted traditional approval by the US Food and Drug Administration (FDA) to treat ...

In our cover story this month, Danny Buckland looks at how HCPs and patients are partnering to transform care through shared decision-making. As Danny says: “A key challenge is to empower HCPs with ...